FDA Inspection 1062125 — Chiesi USA, Inc.
The FDA completed an inspection of Chiesi USA, Inc. on June 15, 2018 in Cary, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 15, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Cary, NC (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)